
US-based Micell Technologies develops biomedical devices for vascular drug delivery in cardiology.
Founded in Durham, North Carolina, Micell Technologies is a biomedical device company with a core mission to revolutionize interventional cardiology through advanced vascular drug delivery systems. The company's vision is to enhance patient outcomes and improve the efficacy of cardiovascular treatments. Their primary products focus on innovative drug delivery technologies designed to optimize the performance of stents and other vascular devices.
Micell Technologies has garnered attention from notable figures in the biomedical field and has secured investments from key players in the healthcare industry. The company's groundbreaking work has led to significant advancements in drug-eluting stent technology, contributing to improved patient care and treatment success rates. Through its innovative solutions, Micell Technologies continues to make a substantial impact on the field of interventional cardiology.

Micro Medical Solutions

Micron Biomedical

Micro Interventional Devices

eLum Technologies

Mercator Medsystems
mercatormed.com

Micron Solutions

Advanced Microbubbles

Micro-Leads

Iscience Surgical

MicroVascular Tissues
mvtissues.com

Novostent

Mechano-Therapeutics

MicroMed Technology
micromedtech.com

BioInspire Technologies

Guided Delivery Systems
Companies similar to Micell Technologies include Micro Medical Solutions, Micron Biomedical, Micro Interventional Devices and eLum Technologies.
Micell Technologies was founded in 1996.
Micell Technologies' headquarters is located in Durham, NC, US.
Micell Technologies' most recent funding round was for $61.8M (USD) in September 2017.
As of Sep 19, 2017, Micell Technologies has raised a total of $90.1M (USD).